Lisa Kurian, M.D.
NPI 1003876228ActiveIndividual· General Practice· Old Greenwich, CT
Opted out of Medicare from May 2025 to May 2027. General Practice (M.D.) in Old Greenwich, Connecticut, licensed in CT and NY, with an NPI issued in March 2006. 336 Medicare patients in 2024, $134,140 paid; nearly all of their 3,139 Part D prescriptions were generic (93%). Novo Nordisk Inc was the largest of 3 companies reporting payments in 2025, $64.22 in all, mostly food and beverage.
Overview
| NPI | 1003876228 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Mar 23, 2006 |
| Last updated in NPPES | Jul 10, 2025 |
| Certified by provider | Jul 10, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| General Practice Primary | 208D00000X | 47809 | CT |
| Internal Medicine | 207R00000X | 232576 | NY |
| Internal Medicine | 207R00000X | 047809 | CT |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out May 19, 2025 – May 19, 2027 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 336 |
|---|---|
| Services billed | 1,595 across 38 procedure codes |
| Paid by Medicare | $134,140 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,139 · 7,522 30-day fills |
|---|---|
| Patients | 410 |
| Total drug cost | $126,919 |
| Generic share | 93% of claims |
Industry payments (Open Payments)
- 2025$64.22 · 3 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $24.44 | 1 |
| Ars Pharmaceuticals Operations, Inc. | $20.12 | 1 |
| Lilly USA, LLC | $19.66 | 1 |
What the 2025 payments were for
- Food and Beverage$64.22 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records